Assertio (also known as Zyla Life Sciences, formerly Egalet) is a specialty pharma company focusing on pain management. The company develops a pipeline of abuse-resistant opioids that are nearing pivotal testing. It offers delivery technologies that enable the controlled release of drugs through the gradual erosion of a tablet and has optimized the abuse-deterrent properties that can be applied to a broad range of opioids and non-opioids.